George V Migausky - Net Worth and Insider Trading
George V Migausky Net Worth
The estimated net worth of George V Migausky is at least $7 Million dollars as of 2024-07-16. George V Migausky is the Director of Immunovant Inc and owns about 109,808 shares of Immunovant Inc (IMVT) stock worth over $3 Million. George V Migausky is also the EVP & CFO of Dyax Corp and owns about 86,350 shares of Dyax Corp (DYAX) stock worth over $3 Million. Details can be seen in George V Migausky's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that George V Migausky has not made any transactions after 2023-12-01 and currently still holds the listed stock(s).
Transaction Summary of George V Migausky
George V Migausky Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, George V Migausky owns 7 companies in total, including Abeona Therapeutics Inc (ABEO) , Immunovant Inc (IMVTU) , and Dimension Therapeutics Inc (DMTX) among others .
Click here to see the complete history of George V Migausky’s form 4 insider trades.
Insider Ownership Summary of George V Migausky
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ABEO | Abeona Therapeutics Inc | 2020-06-17 | director |
IMVTU | Immunovant Inc | 2020-05-15 | director |
DMTX | Dimension Therapeutics Inc | 2017-11-07 | director |
2017-04-06 | Interim CFO | ||
2016-01-22 | EVP & Chief Financial Officer | ||
2021-09-03 | director | ||
2023-12-01 | director |
George V Migausky Latest Holdings Summary
George V Migausky currently owns a total of 2 stocks. Among these stocks, George V Migausky owns 109,808 shares of Immunovant Inc (IMVT) as of December 1, 2023, with a value of $3 Million and a weighting of 50.59%. George V Migausky also owns 86,350 shares of Dyax Corp (DYAX) as of August 17, 2015, with a value of $3 Million and a weighting of 49.41%.
Latest Holdings of George V Migausky
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
IMVT | Immunovant Inc | 2023-12-01 | 109,808 | 30.92 | 3,395,263 |
DYAX | Dyax Corp | 2015-08-17 | 86,350 | 38.41 | 3,316,704 |
Holding Weightings of George V Migausky
George V Migausky Form 4 Trading Tracker
According to the SEC Form 4 filings, George V Migausky has made a total of 2 transactions in Immunovant Inc (IMVT) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Immunovant Inc is the sale of 12,700 shares on December 1, 2023, which brought George V Migausky around $504,571.
According to the SEC Form 4 filings, George V Migausky has made a total of 0 transactions in Dyax Corp (DYAX) over the past 5 years. The most-recent trade in Dyax Corp is the sale of 125,000 shares on August 17, 2015, which brought George V Migausky around $3 Million.
Insider Trading History of George V Migausky
- 1
George V Migausky Trading Performance
GuruFocus tracks the stock performance after each of George V Migausky's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by George V Migausky is 19.07%. GuruFocus also compares George V Migausky's trading performance to market benchmark return within the same time period. The performance of stocks bought by George V Migausky within 3 months outperforms 2 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how George V Migausky's insider trading performs compared to the benchmark.
Performance of George V Migausky
George V Migausky Ownership Network
Ownership Network List of George V Migausky
Ownership Network Relation of George V Migausky
George V Migausky Owned Company Details
What does Abeona Therapeutics Inc do?
Who are the key executives at Abeona Therapeutics Inc?
George V Migausky is the director of Abeona Therapeutics Inc. Other key executives at Abeona Therapeutics Inc include Chief Financial Officer Christine Berni Silverstein , SVP & General Counsel Brendan M. O'malley , and director & Chief Executive Officer Vishwas Seshadri .
Abeona Therapeutics Inc (ABEO) Insider Trades Summary
Over the past 18 months, George V Migausky made no insider transaction in Abeona Therapeutics Inc (ABEO). Other recent insider transactions involving Abeona Therapeutics Inc (ABEO) include a net sale of 7,443 shares made by Michael Amoroso , a net sale of 40,177 shares made by Mark Alvino , and a net purchase of 50,000 shares made by Vishwas Seshadri .
In summary, during the past 3 months, insiders sold 51,711 shares of Abeona Therapeutics Inc (ABEO) in total and bought 42,758 shares, with a net sale of 8,953 shares. During the past 18 months, 95,347 shares of Abeona Therapeutics Inc (ABEO) were sold and 88,758 shares were bought by its insiders, resulting in a net sale of 6,589 shares.
Abeona Therapeutics Inc (ABEO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Abeona Therapeutics Inc Insider Transactions
George V Migausky Mailing Address
Above is the net worth, insider trading, and ownership report for George V Migausky. You might contact George V Migausky via mailing address: C/o Dyax Corp., 300 Technology Square, Cambridge Ma 02139.